• Home
  • Search Results

Search Results

2527 studies match your search
Not currently enrolling

Athletic trainers and concussion risk reduction strategies

To determine how Athletic Trainers' perceive the effectiveness of concussion risk reduction strategies and how their experiences vary in dealing with concussion risk reduction strategies.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
Coming Soon

Study of MRTX1719 in Patients with Advanced Cancer and a Specific Genetic Change

This study is testing a new drug called MRTX1719. The main goal is to find the best dose of the drug to use in future studies. The study will also look at what side effects the drug may cause and how often they happen. Researchers will also measure how quickly the drug is absorbed into the bloodstream and how fast the body gets rid of it. Additionally, they will check how well MRTX1719 works against cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung, Pancreatic, Phase 1 Trials (all cancers))
Not currently enrolling

Study of LY3537982 and Immunotherapy with or Without Chemotherapy for People with Non-Small Cell Lung Cancer

The purpose of this study is to see if adding LY3537982 to standard cancer treatments works better than just using the standard treatments alone for people with advanced non-small cell lung cancer (NSCLC) who have not yet been treated.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lung)
Open

Study on How Volrustomig Works with Other Cancer Drugs for Treating Tumors

If you have non-squamous non-small cell lung cancer and are not currently in treatment, you may qualify for a clinical trial testing a new drug to treat tumors-study drug provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lung)
Open

Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI MyeloMATCH Clinical Trials

Are you newly diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and looking for treatment options? Our study is evaluating new therapies specifically designed for patients with these conditions. If you have not previously tried an anti-cancer therapy for AML/MDS, this study might be for you!

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Solid Tumors Treatment Study

Do you have a solid tumor that has progressed on other treatments? Do you have at least one measurable tumor? If so, you may be able to take part in a study to improve treatment for advanced solid tumors. We are exploring how safe and effective a combination of drugs is.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Phase 1 Trials (all cancers))
Open

NETs Treatment Study

Have you been diagnosed with a neuroendocrine cancer that has not responded to other treatment options? If so then you may be eligible to participate in a study to examine the safety and effectiveness of a new cancer therapy designed to target specific neuroendocrine tumors cells.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Phase 1 Trials (all cancers))

Emotional Well-being in Breast Cancer Survivors

The purpose of this study is to interview breast cancer survivors in North Carolina to understand how various factors have impacted their emotional well-being

Age & Gender
  • 20 years ~ 75 years
  • Female
Study Interest
  • Cancer (Breast)
  • Mental and Emotional Health
  • Women's Health
Visit Location
100% Remote (online, phone, text)
Open

Post-partum Pain Study

Have you had a baby in the past year? If so, you may be able to take part in a study to see how often women have knee pain in the year after they have a baby. The study also looks at whether knee pain makes it harder for women to return to the same level of physical activity they had before pregnancy. Compensation provided.

Age & Gender
  • 18 years ~ 54 years
  • Female
Study Interest
  • Bones, Joints, Muscles
  • Parents of Children
  • Women's Health
  • and 2 more
Visit Location
100% Remote (online, phone, text)
Open

Severe Aplastic Anemia Treatment Study

Have you been diagnosed with Severe Aplastic Anemia (SAA), but don't have a matched sibling donor? If so, you may be able to take part in a study to see if a bone marrow transplant from a donor that is not related can help treat your disease. Compensation provided.

Age & Gender
  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research